| 000 | 01573 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512012217.0 | ||
| 264 | 0 | _c19890427 | |
| 008 | 198904s 0 0 eng d | ||
| 022 | _a0016-5085 | ||
| 024 | 7 |
_a10.1016/0016-5085(89)91636-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdler, G | |
| 245 | 0 | 0 |
_aDifferential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. _h[electronic resource] |
| 260 |
_bGastroenterology _cApr 1989 |
||
| 300 |
_a1158-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aCholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEsters |
| 650 | 0 | 4 | _aFeedback |
| 650 | 0 | 4 |
_aGabexate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGlutamine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPancreas _xdrug effects |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xmetabolism |
| 650 | 0 | 4 |
_aProglumide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPulse _xdrug effects |
| 650 | 0 | 4 | _aReference Values |
| 700 | 1 | _aReinshagen, M | |
| 700 | 1 | _aKoop, I | |
| 700 | 1 | _aGöke, B | |
| 700 | 1 | _aSchafmayer, A | |
| 700 | 1 | _aRovati, L C | |
| 700 | 1 | _aArnold, R | |
| 773 | 0 |
_tGastroenterology _gvol. 96 _gno. 4 _gp. 1158-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0016-5085(89)91636-3 _zAvailable from publisher's website |
| 999 |
_c2653470 _d2653470 |
||